Administration of the PARP inhibitor Pj34 ameliorates the impaired vascular function associated with enos-/-mice

Reproductive Sciences

Volumn 19, Issue 8, 2012, Pages 806-813

  English, Fred A ^a   McCarthy, Fergus P ^a   Andersson, Irene J ^b   Stanley, Joanna L ^b   Davidge, Sandra T ^b   Baker, Philip N ^b   Walsh, Sarah K ^c   Kenny, Louise C ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

intrauterine growth restriction; nitric oxide; poly(ADP ribose) polymerase; preeclampsia; vascular dysfunction

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UTERINE ARTERY; VASCULAR DISEASE;

ANIMALS; ENZYME INHIBITORS; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; UTERINE ARTERY;

EID: 84864342499     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111433885     Document Type: Article

References (47)

1. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol. 2000; 11 (1). 11-14
2. Yinon Y, Kingdom JC, Odutayo A, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation. 2010 ; 122 (18). 1846-1853
3. Kusinski LC, Baker PN, Sibley CP, Wareing M. In Vitro Assessment of mouse uterine and fetoplacenal vascular function. Reprod Sci. 2009 ; 16 (8). 740-748
4. Marsal K. Intrauterine growth restriction. Current Opin Obstet Gynecol. 2002 ; 14 (2). 127-135 (Pubitemid 34269378)
5. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002 ; 287 (24). 3183-3186 (Pubitemid 34686089)
6. van der Heijden OW, Essers YP, Fazzi G, Peeters LL, De Mey JG, van Eys GJ. Uterine artery remodeling and reproductive performance are impaired in endothelial nitric oxide synthase-deficient mice. Biol Reprod. 2005 ; 72 (5). 1161-1168 (Pubitemid 40547980)
7. Veerareddy S, Cook CL, Baker PN, Davidge ST. Vascular adaptions to pregnancy in mice-effects on myogenic tone. Am J Physiol Heart Circ Physiol. 2002 ; 283 (6). H2226 - H2233
8. Cook CL, Davidge ST. Pregnancy induced alterations of vascular function in mouse mesenteric and uterine arteries. Biol Reprod. 2003 ; 68 (3). 1072-1077 (Pubitemid 36245856)
9. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006 ; 195 (1). 40-49 (Pubitemid 43927490)
10. Campbell S, Diaz-Recasens J, Griffin DR, et al. New doppler technique for assessing uteroplacental blood flow. Lancet. 1983 ; 1 (8326). 675-677 (Pubitemid 13158427)
11. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001 ; 285 (12). 1607-1612 (Pubitemid 32240253)
12. Zou MH, Cohen R, Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium. 2004 ; 11 (2). 89-97 (Pubitemid 39207182)
13. Virág L, Szabó C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 2002 ; 54 (3). 375-429
14. Szabo C. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol. 2009 ; 156 (5). 713-727
15. Pacher P, Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol. 2008 ; 173 (1). 2-13 (Pubitemid 351947950)
16. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabó E, Szabó C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes. 2002 ; 51 (2). 514-521 (Pubitemid 34764811)
17. Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabó C. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med. 2002 ; 9 (6). 659-654
18. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002 ; 283 (1). R29 - R45
19. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997 ; 272 (2 pt 2). 441-463
20. Anumba DO, Robson SC, Boys RJ, Ford GA. Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am J Physiol. 1999 ; 277 (2 pt 2). 848-854
21. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun. 1994 ; 205 (1). 905-910 (Pubitemid 24381711)
22. Huang PL. Mouse models of nitric oxide synthase deficiency. J Am Soc Nephrol. 2000 ; 11 (suppl 16). S120 - S123
23. Zhang Y, Kaufman S. Effect of nitric oxide synthase inhibition on cardiovascular and hormonal regulation during pregnancy in the rat. Can J Physiol Pharmacol. 2000 ; 78 (5). 423-427 (Pubitemid 30354466)
24. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995 ; 377 (6546). 239-242
25. Osol G, Cipolla M. Pregnancy-induced changes in the three-dimensional mechanical properties of pressurized rat uteroplacental (radial) arteries. Am J Obstet Gynecol. 1993 ; 168 (1). 268-274 (Pubitemid 23047651)
26. Otis EM, Brent R. Equivalent ages in mouse and human embryos. Anat Rec. 1954 ; 120 (1). 33-66
27. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabó C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res. 2001 ; 89 (8). 684-691 (Pubitemid 34627068)
28. Barut F, Barut A, Gun BD, et al. Intrauterine growth restriction and placental angiogenesis. Diagn Pathol. 2010 ; 5: 24
29. Huang PL. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab. 2009 ; 20 (6). 295-302
30. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996 ; 271 (5 pt 1). C1424 - C1437
31. Crocker IP, Kenny LC, Thornton WA, Szabo C, Baker PN. Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia. Br J Pharmacol. 2005 ; 144 (6). 772-780 (Pubitemid 40516117)
32. Cosentino F, Paton S, d'Uscio LV, et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rat. J Clin Invest. 1998 ; 101 (7). 1530-1537 (Pubitemid 28166851)
33. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994 ; 298 (pt 2). 249-258 (Pubitemid 24072462)
34. Purcell TL, Buhimschi IA, Given R, Chwalisz K, Garfield RE. Inducible nitric oxide synthase is present in the rat placenta at the fetal-maternal interface and decreases prior to labour. Mol Hum Reprod. 1997 ; 3 (6). 485-491 (Pubitemid 127509368)
35. Kwon H, Wu G, Meininger CJ, Bazer FW, Spencer TE. Developmental changes in nitric oxide synthesis in the ovine placenta. Biol Reprod. 2004 ; 70 (3). 679-686 (Pubitemid 38233706)
36. Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer I, Lyall F. Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. Placenta. 1997 ; 18 (4). 261-268 (Pubitemid 27214229)
37. Morikawa M, Inoue M, Tokumaru S, Kogo H. Enhancing and inhibitory effects of nitric oxide on superoxide anion generation in human polymorphonuclear leukocytes. Br J Pharmacol. 1995 ; 115 (7). 1302-1306
38. Seth P, Kumari R, Dikshit M, Srimal RC. Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine. Blood. 1994 ; 84 (8). 2741-2748 (Pubitemid 24317408)
39. Goebel DJ, Winkler BS. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina. J Neurochem. 2006 ; 98 (6). 1732-1745 (Pubitemid 44298241)
40. Scott GS, Virág L, Szabó C, Hooper DC. Peroxynitrite- induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia. 2003 ; 41 (2). 101-116
41. Shesely EG, Gilbert C, Granderson G, Carretero CD, Carretero OA, Beierwaltes WH. Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy. Am J Obstet Gynecol. 2001 ; 185 (5). 1198-1203 (Pubitemid 33097387)
42. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999 ; 33 (1). 83-89 (Pubitemid 29061846)
43. Krause BJ, Hanson MA, Casanello P. Role of nitric oxide in placental vascular development and function. Placenta. 2011 ; 32 (11). 797-805
44. Myatt L, Eis AL, Brockman DE, Greer IA, Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod. 1997 ; 12 (1). 167-172 (Pubitemid 27077619)
45. Biswas S, Ghosh SK. Gross morphological changes of placentas associated with intrauterine growth restriction of fetuses: a case control study. Early Hum Dev. 2008 ; 84 (6). 357-362
46. Shehata F, Levin I, Shrim A, et al. Placenta/birthweight ratio and perinatal outcome: a retrospective cohort analysis. BJOG. 2011 ; 118 (6). 741-747
47. Van Vliet BN, Chafe LL. Maternal endothelial nitric oxide synthase genotype influences offspring blood pressure and activity in mice. Hypertension. 2007 ; 49 (3). 556-562